Ieq Capital LLC Reduces Stock Holdings in Maximus, Inc. $MMS

Key Points

• Ieq Capital LLC has decreased its position in Maximus, Inc. by 39.8% in the first quarter, now holding 4,363 shares worth approximately $298,000.
• Several institutional investors have significantly increased their holdings in Maximus, including Caitong International Asset Management, which raised its stake by 17,533.3%.
• Maximus recently reported earnings of $2.16 EPS, surpassing analyst expectations and demonstrating a year-over-year revenue growth of 2.5%.

Ieq Capital LLC cut its position in Maximus, Inc. (NYSE:MMS - Free Report) by 39.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,363 shares of the health services provider's stock after selling 2,882 shares during the quarter. Ieq Capital LLC's holdings in Maximus were worth $298,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Captrust Financial Advisors bought a new position in Maximus in the 4th quarter worth about $276,000. GAMMA Investing LLC increased its position in shares of Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after purchasing an additional 294 shares during the last quarter. Blue Trust Inc. lifted its stake in Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Maximus in the first quarter worth $2,115,000. Finally, Janney Montgomery Scott LLC grew its position in Maximus by 70.5% during the 1st quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after acquiring an additional 4,196 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

MMS traded down $0.93 during trading on Tuesday, hitting $87.41. 591,056 shares of the company traded hands, compared to its average volume of 569,126. The company has a market cap of $4.93 billion, a PE ratio of 16.10 and a beta of 0.61. The stock's 50-day simple moving average is $78.56 and its two-hundred day simple moving average is $72.59. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.94. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, sell-side analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend was Friday, August 15th. Maximus's payout ratio is currently 22.10%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Strong Buy" and an average price target of $90.00.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.